State of the Art in Topical Wound-Healing Products
Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials...
Gespeichert in:
| Veröffentlicht in: | Plastic and reconstructive surgery (1963) 2011-01, Vol.127 (Suppl 1), p.44S-59S |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 59S |
|---|---|
| container_issue | Suppl 1 |
| container_start_page | 44S |
| container_title | Plastic and reconstructive surgery (1963) |
| container_volume | 127 |
| creator | Fan, Kenneth Tang, Jennifer Escandon, Julia Kirsner, Robert S. |
| description | Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials, growth factors, and human skin substitutes, have been devised in an attempt to correct the chronic wound environment. This review addresses these modalities with a focus on evidence and randomized controlled trials. |
| doi_str_mv | 10.1097/PRS.0b013e3181fbe275 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_840347426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>840347426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3510-b0ce391f66132afe6a41b6828737177a36d14316f6e82444b790164640102fca3</originalsourceid><addsrcrecordid>eNpdkFFLwzAUhYMobk7_gUjffOq8N0mT9nEMdcLA4SY-hrRNXLVrZtIy_PdWNhW8Lxcu55x7-Ai5RBgjZPJm8bQcQw7IDMMUbW6oTI7IEBOaxZxyekyGAIzGCAkdkLMQ3gBQMpGckgFFCkAlGxK6bHVrImejdm2iiW-jqolWblsVuo5eXNeU8czoumpeo4V3ZVe04ZycWF0Hc3HYI_J8d7uazuL54_3DdDKPC5YgxDkUhmVohUBGtTVCc8xFSlPJJEqpmSiRMxRWmJRyznOZAQouOCBQW2g2Itf73K13H50JrdpUoTB1rRvjuqBSDoxLTkWv5Htl4V0I3li19dVG-0-FoL5hqR6W-g-rt10dHnT5xpS_ph86f7k7V7fGh_e62xmv1j2Qdq2gH5EwHlNA7EsDxv0FgX0B4Edyog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>840347426</pqid></control><display><type>article</type><title>State of the Art in Topical Wound-Healing Products</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Fan, Kenneth ; Tang, Jennifer ; Escandon, Julia ; Kirsner, Robert S.</creator><creatorcontrib>Fan, Kenneth ; Tang, Jennifer ; Escandon, Julia ; Kirsner, Robert S.</creatorcontrib><description>Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials, growth factors, and human skin substitutes, have been devised in an attempt to correct the chronic wound environment. This review addresses these modalities with a focus on evidence and randomized controlled trials.</description><identifier>ISSN: 0032-1052</identifier><identifier>EISSN: 1529-4242</identifier><identifier>DOI: 10.1097/PRS.0b013e3181fbe275</identifier><identifier>PMID: 21200273</identifier><language>eng</language><publisher>United States: American Society of Plastic Surgeons</publisher><subject>Administration, Topical ; Anti-Infective Agents - administration & dosage ; Bandages ; Chronic Disease ; Humans ; Intercellular Signaling Peptides and Proteins - administration & dosage ; Randomized Controlled Trials as Topic ; Skin Transplantation ; Skin, Artificial ; Tissue Engineering ; Wound Healing - drug effects ; Wound Healing - physiology ; Wounds and Injuries - physiopathology ; Wounds and Injuries - therapy</subject><ispartof>Plastic and reconstructive surgery (1963), 2011-01, Vol.127 (Suppl 1), p.44S-59S</ispartof><rights>American Society of Plastic Surgeons</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3510-b0ce391f66132afe6a41b6828737177a36d14316f6e82444b790164640102fca3</citedby><cites>FETCH-LOGICAL-c3510-b0ce391f66132afe6a41b6828737177a36d14316f6e82444b790164640102fca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21200273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, Kenneth</creatorcontrib><creatorcontrib>Tang, Jennifer</creatorcontrib><creatorcontrib>Escandon, Julia</creatorcontrib><creatorcontrib>Kirsner, Robert S.</creatorcontrib><title>State of the Art in Topical Wound-Healing Products</title><title>Plastic and reconstructive surgery (1963)</title><addtitle>Plast Reconstr Surg</addtitle><description>Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials, growth factors, and human skin substitutes, have been devised in an attempt to correct the chronic wound environment. This review addresses these modalities with a focus on evidence and randomized controlled trials.</description><subject>Administration, Topical</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Bandages</subject><subject>Chronic Disease</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - administration & dosage</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Skin Transplantation</subject><subject>Skin, Artificial</subject><subject>Tissue Engineering</subject><subject>Wound Healing - drug effects</subject><subject>Wound Healing - physiology</subject><subject>Wounds and Injuries - physiopathology</subject><subject>Wounds and Injuries - therapy</subject><issn>0032-1052</issn><issn>1529-4242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkFFLwzAUhYMobk7_gUjffOq8N0mT9nEMdcLA4SY-hrRNXLVrZtIy_PdWNhW8Lxcu55x7-Ai5RBgjZPJm8bQcQw7IDMMUbW6oTI7IEBOaxZxyekyGAIzGCAkdkLMQ3gBQMpGckgFFCkAlGxK6bHVrImejdm2iiW-jqolWblsVuo5eXNeU8czoumpeo4V3ZVe04ZycWF0Hc3HYI_J8d7uazuL54_3DdDKPC5YgxDkUhmVohUBGtTVCc8xFSlPJJEqpmSiRMxRWmJRyznOZAQouOCBQW2g2Itf73K13H50JrdpUoTB1rRvjuqBSDoxLTkWv5Htl4V0I3li19dVG-0-FoL5hqR6W-g-rt10dHnT5xpS_ph86f7k7V7fGh_e62xmv1j2Qdq2gH5EwHlNA7EsDxv0FgX0B4Edyog</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Fan, Kenneth</creator><creator>Tang, Jennifer</creator><creator>Escandon, Julia</creator><creator>Kirsner, Robert S.</creator><general>American Society of Plastic Surgeons</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>State of the Art in Topical Wound-Healing Products</title><author>Fan, Kenneth ; Tang, Jennifer ; Escandon, Julia ; Kirsner, Robert S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3510-b0ce391f66132afe6a41b6828737177a36d14316f6e82444b790164640102fca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Topical</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Bandages</topic><topic>Chronic Disease</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - administration & dosage</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Skin Transplantation</topic><topic>Skin, Artificial</topic><topic>Tissue Engineering</topic><topic>Wound Healing - drug effects</topic><topic>Wound Healing - physiology</topic><topic>Wounds and Injuries - physiopathology</topic><topic>Wounds and Injuries - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fan, Kenneth</creatorcontrib><creatorcontrib>Tang, Jennifer</creatorcontrib><creatorcontrib>Escandon, Julia</creatorcontrib><creatorcontrib>Kirsner, Robert S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Plastic and reconstructive surgery (1963)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, Kenneth</au><au>Tang, Jennifer</au><au>Escandon, Julia</au><au>Kirsner, Robert S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>State of the Art in Topical Wound-Healing Products</atitle><jtitle>Plastic and reconstructive surgery (1963)</jtitle><addtitle>Plast Reconstr Surg</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>127</volume><issue>Suppl 1</issue><spage>44S</spage><epage>59S</epage><pages>44S-59S</pages><issn>0032-1052</issn><eissn>1529-4242</eissn><abstract>Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials, growth factors, and human skin substitutes, have been devised in an attempt to correct the chronic wound environment. This review addresses these modalities with a focus on evidence and randomized controlled trials.</abstract><cop>United States</cop><pub>American Society of Plastic Surgeons</pub><pmid>21200273</pmid><doi>10.1097/PRS.0b013e3181fbe275</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0032-1052 |
| ispartof | Plastic and reconstructive surgery (1963), 2011-01, Vol.127 (Suppl 1), p.44S-59S |
| issn | 0032-1052 1529-4242 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_840347426 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Administration, Topical Anti-Infective Agents - administration & dosage Bandages Chronic Disease Humans Intercellular Signaling Peptides and Proteins - administration & dosage Randomized Controlled Trials as Topic Skin Transplantation Skin, Artificial Tissue Engineering Wound Healing - drug effects Wound Healing - physiology Wounds and Injuries - physiopathology Wounds and Injuries - therapy |
| title | State of the Art in Topical Wound-Healing Products |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A38%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=State%20of%20the%20Art%20in%20Topical%20Wound-Healing%20Products&rft.jtitle=Plastic%20and%20reconstructive%20surgery%20(1963)&rft.au=Fan,%20Kenneth&rft.date=2011-01-01&rft.volume=127&rft.issue=Suppl%201&rft.spage=44S&rft.epage=59S&rft.pages=44S-59S&rft.issn=0032-1052&rft.eissn=1529-4242&rft_id=info:doi/10.1097/PRS.0b013e3181fbe275&rft_dat=%3Cproquest_cross%3E840347426%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=840347426&rft_id=info:pmid/21200273&rfr_iscdi=true |